Table 3

Results of initial mannitol challenge test according to current asthma therapy and outcome of the challenge test

<10% fall in FEV1; no medical contraindications to dive (n=21)>10% fall in FEV1; rechallenge offered (n=14)>10% fall in FEV1; not interested in rechallenge, unfit to dive (n=6)
SABA14114
ICS (no LABA)
 Low (200–400)632
 Medium (>400–800)220
 High (>800)101
ICS (LABA add-on)
 Low (200–400)122
 Medium (>400–800)210
 High (>800)100
 LABA (no ICS)100
 LAMA000
  • FEV1, forced expiratory volume in 1 s; ICS, inhaled corticosteroid; LABA, long-acting beta2 agonist; LAMA, long-acting muscarinic antagonist; SABA, short-acting beta2 agonist.